Clinical Trial Update: Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a triple combination of binimetinib, palbociclib, and TAS-102 in KRAS- or NRAS-mutant metastatic or unresectable colorectal cancer; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Binimetinib (binimetinib)
• Palbociclib (palbociclib)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2022-12-29